1. Ahmed AS, Dew T, Lawton FG, Papadopoulos AJ, Devaja O, Raju KS, Sherwood RA (2007) M2-PK as a novel marker in ovarian cancer. A prospective cohort study. Eur J Gynaecol Oncol 28:83–88
2. Castaldo G, Calcagno G, Sibillo R, Cuomo R, Nardone G, Castellano L, Del Vecchio BC, Budillon G, Salvatore F (2000) Quantitative analysis of aldolase A mRNA in liver discriminates between hepatocellular cancer and cirrhosis. Clin Chem 46:901–906
3. Cooper EH (1994) Neuron-specific enolase. Int J Biol Markers 9:205–210
4. Demir AS, Erdenen F, Müderrisoglu C, Toros AB, Bektas H, Gelisgen R, Tabak O, Altunoglu E, Uzun H, Huq GA, Aral H (2013) Diagnostic and prognostic value of tumor M2-pyruvate kinase levels in patients with colorectal cancer. Turk J Gastroenterol 24:36–42
5. Dhar DK, Olde Damink SWM, Brindley JH, Godfrey A, Chapman MH, Sandanayake NS, Andreola F, Mazurek S, Hasan T, Malago M, Pereira SP (2013) Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer. Cancer 119:575–585